Add BrightSurf on Google Email

The Lancet


Preventive antibiotic use significantly lowers risk of infection with antibiotic-resistant bacteria in intensive care patients

A large randomized trial found that preventive antibiotic use significantly reduces the risk of infection with highly resistant microorganisms in intensive care patients. Patients treated with selective digestive tract decontamination (SDD) were 59% less likely to develop bacteraemia and 38% less likely to colonize respiratory tracts.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateMar 20, 2011

Official projections have substantially underestimated the cholera epidemic in Haiti but combining available interventions could prevent thousands of deaths

A new study predicts nearly 800,000 cases and 11,100 deaths in Haiti due to cholera, significantly underestimating official projections. Combining available disease control strategies such as clean water access, oral vaccination, and expanded antibiotic use could prevent thousands of deaths.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 15, 2011

Study of 143,000 children shows reference heart rate and breathing rate ranges differ widely from published guidelines

A new analysis of 69 studies involving 143,000 healthy children has identified new reference ranges for heart rate and respiratory rate that differ significantly from existing guidelines. The study found a decline in respiratory rate from birth to early adolescence, with infants under 2 years showing the steepest fall.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 14, 2011

Transmitted drug resistant HIV (Europe/USA) significantly increases likelihood of treatment failure: this can be minimized by testing for resistance before starting therapy

A recent study found that transmitted drug-resistant (TDR) HIV significantly increases the likelihood of treatment failure, with patients more than three times as likely to experience virological failure. However, pre-treatment genotypic testing and use of ritonavir-boosted protease inhibitors can minimize this risk.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateFeb 27, 2011

Failure to tackle UK's alcohol problem could see many thousands of extra liver deaths than in other European countries

The UK's failure to address its alcohol problem could result in a significant increase in liver deaths, with the country facing a projected 77,000 excess deaths over 20 years if it doesn't adopt effective policies. The authors argue that increasing alcohol quality and limiting availability of cheap products can help reduce death rates.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2011

Tobacco companies expand their epidemic of death

The tobacco industry is expanding its sales in Africa, the Middle East, and Asia Pacific, with Imperial Tobacco and Phillip Morris reporting increases in cigarette sales. The Lancet Editorial criticizes the companies' 'selling, addicting, and killing' business model, describing it as 'morally repugnant'.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 9, 2011

Country-by-country trends in obesity, cholesterol and blood pressure since 1980: Obesity has doubled, while Western wealthy countries have reduced blood pressure and cholesterol levels

The prevalence of obesity has nearly doubled globally, with women more likely to be obese than men. Meanwhile, high-income countries have shown impressive reductions in mean blood pressure and cholesterol levels, with some countries performing better than others.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 3, 2011

Researchers identify 5 new genetic variations in total of 11 thought to be important in Parkinson's disease risk

Researchers have identified five additional genetic variations that contribute significantly to Parkinson's disease risk, with 20% of patients carrying high-risk variants being two-and-a-half times more likely to develop PD. The study highlights the importance of common genetic variation in the development of this debilitating condition.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 1, 2011

Study reveals effective anti-HIV drugs for starting treatment in children with HIV, and shows that delaying switching to second-line drugs does not affect long-term benefit

A new study found that protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs) are equally effective as initial treatment for children with HIV, delaying switch to second-line drugs does not impact long-term outcomes. Regular monitoring of viral load is crucial to prevent resistance.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateJan 31, 2011

The end of our national health service

The Lancet Editorial warns that the UK government's Health and Social Care Bill will fundamentally change the National Health Service (NHS), shifting from a national to individualized care model. The proposed reforms have sparked fears about patient outcomes, access to healthcare, and the overall future of the NHS.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 27, 2011

Certain genetic profiles increase risk of coronary artery disease while others uniquely increase risk of heart attacks in those with coronary disease; blood group O offers protection

A new study identifies genetic variants associated with coronary artery disease (CAD) and heart attacks. The researchers found that certain genetic profiles increase the risk of CAD and heart attacks in individuals with CAD, while blood group O offers protection against heart attacks.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 14, 2011